Immediate Impact
54 standout
Citing Papers
Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets
2024 Standout
2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
2023 Standout
Works of Tomas Nuño being referenced
Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Tomas Nuño | 81 | 134 | 80 | 138 | 26 | 383 | |
| Elder Granger | 45 | 84 | 35 | 77 | 28 | 408 | |
| Ho Kyung Sung | 22 | 68 | 64 | 89 | 42 | 436 | |
| Jonathan Matenga | 15 | 122 | 51 | 86 | 25 | 407 | |
| Nerea Fernández de Larrea | 19 | 49 | 32 | 126 | 22 | 415 | |
| Timothy Simmons | 43 | 67 | 47 | 45 | 31 | 399 | |
| Henry Ddungu | 46 | 51 | 36 | 138 | 32 | 455 | |
| Brian Dulisse | 33 | 92 | 28 | 70 | 18 | 441 | |
| Anand Kartha | 124 | 49 | 94 | 82 | 24 | 397 | |
| Yesika Díaz | 50 | 64 | 17 | 67 | 33 | 380 | |
| Manasi Shirke | 51 | 56 | 21 | 112 | 19 | 415 |
All Works
Login with ORCID to disown or claim papers
Loading papers...